Table 3.
Changes in muscle strength and muscle enzymes of patients with one-month glucocorticoids or riboflavin treatment
| Variables | Glucocorticoids group, median (range) | Riboflavin group, median (range) | Z | P | ||||
|---|---|---|---|---|---|---|---|---|
| Baseline | 1 month | n | Baseline | 1 month | n | |||
| Neck muscle | 8 (2, 9) | 8 (4, 10) | 11 | 7 (1, 9) | 10 (6, 10) | 27 | −2.400 | 0.016* |
| Proximal upper limbs | 9 (8, 10) | 9 (5, 10) | 15 | 9 (6, 10) | 10 (9, 10) | 27 | −2.206 | 0.027* |
| Proximal lower limbs | 8 (5, 10) | 8 (5, 10) | 15 | 8 (2, 10) | 10 (6, 10) | 27 | −4.318 | <0.001* |
| CK (U/L) | 878 (316, 2526) | 373 (31, 2729) | 15 | 718 (168, 2231) | 112 (27, 5236) | 23 | −0.164 | 0.870 |
| LDH (U/L) | 861 (253, 3054) | 819 (164, 10771) | 13 | 630 (311, 3507) | 304 (159, 3085) | 23 | −1.301 | 0.193 |
| AST (U/L) | 146 (40, 447) | 82 (21, 775) | 14 | 109 (37, 317) | 35 (8, 138) | 23 | −0.830 | 0.407 |
*P<0.05 is considered to be significant. CK: Creatinine kinase; AST: Aspartate aminotransferase; LDH: Lactate dehydrogenase.